Indiana legislation · 2026 Regular Session
Indiana SB262: INSPECT program.
Status: Signed into law, February 27, 2026
Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.
What the bill says
An act to amend the Indiana Code concerning professions and occupations.
From the enrolled text:
AN ACT to amend the Indiana Code concerning professions and occupations. SECTION 1. IC 25-26-24-3, AS ADDED BY P.L.51-2019, SECTION 8, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE JULY 1, 2026]: Sec. 3. (a) As used in this chapter, "dispense" means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner and includes the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery. (b) The term does not apply to the following: (1) A drug administered directly to a patient. (2) A drug dispensed by a practitioner, if the quantity dispensed is not more than a seventy-two (72) hour supply of a controlled substance listed in schedule II, III, IV, or V as set forth in IC 35-48-3-9. SECTION 2. IC 25-26-24-12.5 IS ADDED TO THE INDIANA CODE AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY 1, 2026]: Sec. 12.5. "Prescription drug monitoring program data", for purposes of section 19 of this chapter, means the following: (1) Information received under section 17 of this chapter, including clinical or required alerts as defined by the board. (2) Any other information determined by the board, SEA 262 -- Concur including: (A) a report concerning controlled substance poisonings or overdoses; and (B) information concerning …
Sponsors
- Michael Crider (R, SD-028) · primary sponsor
- Ed Charbonneau (R, SD-005)
Latest actions
- : Public Law 133
- : Signed by the Governor
- : Signed by the Speaker
- : Signed by the President Pro Tempore
- : Signed by the President of the Senate
- : Senate concurred with House amendments; Roll Call 287: yeas 47, nays 0
- : Returned to the Senate with amendments
- : Motion to concur filed
- : Third reading: passed; Roll Call 312: yeas 94, nays 0
- : Second reading: ordered engrossed
Votes
- SB0262.04.COMH.CON01 (February 25, 2026): 47 yea, 0 nay, passed
- SB0262.04.COMH (February 23, 2026): 94 yea, 0 nay, passed
- SB0262.03.ENGS (January 28, 2026): 48 yea, 0 nay, passed
Subjects: AGENCIES; Department of Health (IDOH), HEALTH CARE FACILITIES; Pharmacies, HEALTH CARE PROFESSIONALS; Pharmacists, AGENCIES; Family and Social Services Administration (FSSA), AGENCIES; Professional Licensing Agency (PLA), HEALTH; Prescription Drugs and Medications
Common questions
- What is SB262?
- SB262 is a bill in the Indiana Legislature (2026 Regular Session): INSPECT program.
- What does SB262 do?
- In its own words: An act to amend the Indiana Code concerning professions and occupations.
- What is the status of SB262?
- Signed into law as of February 27, 2026. Latest action: Public Law 133 (March 5, 2026).
- Who sponsored SB262?
- Michael Crider (R, SD-028), with 1 co-sponsor.
- Where is the official record for SB262?
- On the Indiana Legislature website: https://iga.in.gov/legislative/2026/bills/senate/262
Source: official Indiana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.